Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-26
DOI
10.1002/mds.28595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Levodopa infusion in Parkinson's disease: Individual quality of life
- (2020) Claas Ehlers et al. ACTA NEUROLOGICA SCANDINAVICA
- Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study
- (2020) Harmen Moes et al. Journal of Parkinsons Disease
- Contemporary Options for the Management of Motor Complications in Parkinson’s Disease: Updated Clinical Review
- (2019) Verónica Cabreira et al. DRUGS
- Long‐term effect of levodopa‐carbidopa intestinal gel on axial signs in Parkinson’s disease
- (2019) Margherita Fabbri et al. ACTA NEUROLOGICA SCANDINAVICA
- Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study
- (2019) Leonardo Lopiano et al. JOURNAL OF NEUROLOGY
- Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation
- (2019) Daniel Richter et al. JOURNAL OF NEURAL TRANSMISSION
- Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
- (2019) Werner Poewe et al. Journal of Parkinsons Disease
- Long‐term safety and efficacy of 24‐hour levodopa‐carbidopa intestinal gel in Parkinson's disease
- (2019) Hugo Morales‐Briceño et al. MOVEMENT DISORDERS
- Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors
- (2019) Carlo Alberto Artusi et al. PARKINSONISM & RELATED DISORDERS
- Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel
- (2019) Massimo Marano et al. PARKINSONISM & RELATED DISORDERS
- Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy
- (2018) T. Sahlström et al. ACTA NEUROLOGICA SCANDINAVICA
- Impulse control disorders in Parkinson’s disease
- (2018) Ana Marques et al. JOURNAL OF NEURAL TRANSMISSION
- Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease
- (2018) Angelo Antonini et al. JOURNAL OF NEURAL TRANSMISSION
- Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease
- (2018) Maria Jose Catalan et al. JOURNAL OF NEUROLOGY
- Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
- (2018) Alessandro Tessitore et al. JOURNAL OF NEUROLOGY
- Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers
- (2018) Rosella Ciurleo et al. JOURNAL OF NEUROLOGY
- Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease
- (2018) Maurizio Zibetti et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease
- (2018) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
- (2018) Houyam Tibar et al. Frontiers in Neurology
- Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson’s Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson’s Disease Questionnaire
- (2018) Ali S. Shalash et al. Frontiers in Neurology
- Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson’s Disease
- (2018) Kristina Rosqvist et al. Journal of Parkinsons Disease
- Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2018) Libo Wang et al. Frontiers in Neurology
- Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review
- (2018) Vibhash D. Sharma et al. Frontiers in Neurology
- Adjunctive Therapies in Parkinson’s Disease: How to Choose the Best Treatment Strategy Approach
- (2018) Margherita Fabbri et al. DRUGS & AGING
- Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease
- (2018) M. Fabbri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel
- (2018) K. Ray Chaudhuri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation
- (2018) Ignacio Regidor et al. Journal of Parkinsons Disease
- Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features
- (2017) María-José Catalán et al. MOVEMENT DISORDERS
- Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson’s disease: An open-label study
- (2017) Annamária Juhász et al. PARKINSONISM & RELATED DISORDERS
- Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up
- (2017) Mariachiara Sensi et al. PARKINSONISM & RELATED DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
- (2017) Angelo Antonini et al. PARKINSONISM & RELATED DISORDERS
- Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease
- (2017) Mario Meloni et al. PARKINSONISM & RELATED DISORDERS
- Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion
- (2017) Oriol De Fabregues et al. Brain and Behavior
- Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease
- (2017) Xin-Ling Su et al. Translational Neurodegeneration
- Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
- (2016) Karin Wirdefeldt et al. CNS DRUGS
- Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson’s disease
- (2016) Florence C.F. Chang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
- (2016) Angelo Antonini et al. MOVEMENT DISORDERS
- Advanced therapies in Parkinson’s disease: Long-term retrospective study
- (2016) Aristide Merola et al. PARKINSONISM & RELATED DISORDERS
- Choosing an Advanced Therapy in Parkinson’s Disease; is it an Evidence-Based Decision in Current Practice?
- (2016) Frouke A.P. Nijhuis et al. Journal of Parkinsons Disease
- Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease
- (2015) Antoniya Todorova et al. CLINICAL NEUROPHARMACOLOGY
- Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment
- (2015) A. Merola et al. EUROPEAN JOURNAL OF NEUROLOGY
- Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience
- (2015) Saeed Bohlega et al. EUROPEAN NEUROLOGY
- The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
- (2015) O. Băjenaru et al. JOURNAL OF NEURAL TRANSMISSION
- Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials
- (2015) Anthony E. Lang et al. MOVEMENT DISORDERS
- Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials
- (2015) Mark F. Lew et al. PARKINSONISM & RELATED DISORDERS
- Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry
- (2015) Maríateresa Buongiorno et al. PARKINSONISM & RELATED DISORDERS
- Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients
- (2014) Mariachiara Sensi et al. JOURNAL OF NEURAL TRANSMISSION
- Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
- (2014) María T. Cáceres-Redondo et al. JOURNAL OF NEUROLOGY
- Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease
- (2013) M. Zibetti et al. ACTA NEUROLOGICA SCANDINAVICA
- Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
- (2013) M. Zibetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
- (2013) Jens Volkmann et al. JOURNAL OF NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Deep Brain Stimulation May Improve Quality of Life in People With Parkinson's Disease Without Affecting Caregiver Burden
- (2013) Genko Oyama et al. NEUROMODULATION
- Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs
- (2013) Constanze Jugel et al. PLoS One
- Requirements for Parkinson’s disease pharmacotherapy from the patients’ perspective: a questionnaire-based survey
- (2012) Ullrich Wüllner et al. CURRENT MEDICAL RESEARCH AND OPINION
- Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease
- (2012) Karin Busk et al. PARKINSONISM & RELATED DISORDERS
- Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being
- (2011) D. Santos-García et al. ACTA NEUROLOGICA SCANDINAVICA
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
- (2011) Aristide Merola et al. MOVEMENT DISORDERS
- Which measures of physical function and motor impairment best predict quality of life in Parkinson’s disease?
- (2011) T. Ellis et al. PARKINSONISM & RELATED DISORDERS
- Current approaches to the treatment of Parkinson’s disease
- (2011) Joseph Jankovic Neuropsychiatric Disease and Treatment
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More